Related Experiment Video
Updated: Aug 29, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
CNS vasculitis
1Department of Neurology, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA, USA.
Insights
Central nervous system (CNS) vasculitis involves inflammation of brain blood vessels, often immune-mediated. Early recognition and understanding its pathogenesis, including genetic factors, are crucial for effective treatment and preventing severe outcomes.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Central nervous system (CNS) vasculitis encompasses diverse disorders affecting CNS blood vessels.
- It can be primary or secondary to systemic conditions like systemic lupus erythematosus (SLE) or polyarteritis nodosa (PAN).
- Inflammation may be immune-mediated or infectious, with hypersensitivity states and genetic predisposition as potential triggers.
Purpose of the Study:
- To highlight the importance of recognizing CNS vasculitis.
- To discuss the evolving understanding of its pathogenesis.
- To emphasize the need for timely diagnosis and treatment.
Main Methods:
- Review of existing literature on CNS vasculitis.
- Discussion of immune-mediated pathways.
- Exploration of genetic susceptibility factors.
Main Results:
- CNS vasculitis presents with neurological deficits in a vascular distribution.
- Most vasculitides are cell-mediated, with CD4+ T-cell activation implicated in giant cell arteritis.
- Genetic factors contribute to the cascade of vascular injury.
Conclusions:
- Understanding the pathogenesis of CNS vasculitis is key to its recognition and management.
- Cell-mediated immunity and genetic predisposition play significant roles.
- Prompt diagnosis and treatment are essential to avert devastating consequences.
Abstract:
Vasculitis of the central nervous system can be of several varieties depending upon the vessel(s) involved and type of disorder. One can see primary CNS vasculitis as a distinct entity which is primarily manifested as central nervous system injury in a vascular distribution or the vasculitic process can be secondary to a systemic disorder such as systemic lupus erythematosus (SLE) or polyarteritis nodosa (PAN). The inflammation of the CNS vessels can be immune mediated or infectious in nature and a number of "triggers" have been identified including hypersensitivity states. It is quite probable that there is a genetic predisposition in certain individuals and this can lead to an enhanced risk of a vasculitic process when there is exposure to a particular antigen that "sets off" the immune system. The potential for response of the process to antimicrobials and/or immunosuppressants, and the potential for devastating consequences if the process is left untreated, has heightened the urgency in recognizing CNS vasculitis. Key to the recognition and treatment of CNS vasculitis is the evolution of newer insights into the pathogenesis. For example, it is evident that most vasculitides are cell-mediated. Antigen stimulation of CD4+T cells is believed to play a crucial role in giant cell (temporal) arteritis which is the most common type of CNS vasculitis. Identification of genetic susceptibility has also contributed to our understanding of the cascade of events that leads to vascular injury on an inflammatory basis.
Related Concept Videos
Encephalitis ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Vascular Spasm
Arboviral Encephalitis
Encephalitis l: Introduction
Viral Meningitis
